Patients: A total of 302 adult patients with T2D inadequately controlled on SGLT-2i metformin/sulfonylurea were randomized to receive Ozempic injection 1 mg (n=151) once weekly or volume-matched placebo (n=151) as an add-on to SGLT-2i metformin/sulfonylurea
This interaction activates the Akt/mTOR pathway , which is responsible for: Stimulating muscle protein synthesis Promoting cell proliferation and differentiation Enhancing collagen and connective tissue formation Supporting cellular repair and regeneration A review 3 explains that this biochemical process makes IGF-1 LR3 a promising tool for maintaining or regaining muscle mass, particularly during recovery or rehabilitation periods
What happens after potential approval Assuming retatrutide eventually receives FDA approval, several practical questions arise for the research and clinical communities
It holds promise in various disease conditions, particularly in inflammatory bowel disease (IBD) treatment, where it has shown substantial
There are only a few studies, but their results thus far seem promising
People with real weight loss are happier overall